Supplementary Figures.docx (46.81 kB)
Supplementary Figures. Comparative effectiveness of first-line ICIs plus TKIs according to IMDC risk groups in metastatic RCC: a meta-analysis
figure
posted on 2021-04-28, 09:58 authored by Francesco Massari, Alessandro Rizzo, Veronica Mollica, Matteo Santoni, Matteo Rosellini, Andrea Marchetti, Angela Dalia Ricci, Giada Grilli, Alba Greco, Rodolfo Montironi, Andrea Ardizzoni|
Supplementary Figure 1. Funnel Plot of the Overall Survival (OS) in poor-risk patients, according to IMDC criteria (immune checkpoint inhibitors plus tyrosine kinase inhibitors versus sunitinib monotherapy). Supplementary Figure 2. Funnel Plot of the Overall Survival (OS) in intermediate-risk patients, according to IMDC criteria (immune checkpoint inhibitors plus tyrosine kinase inhibitors versus sunitinib monotherapy). |
Supplementary Figure 3. Funnel Plot of the Overall Survival (OS) in favorable-risk patients, according to IMDC criteria (immune checkpoint inhibitors plus tyrosine kinase inhibitors versus sunitinib monotherapy).
